Patents Assigned to Bioceltran Co., Ltd.
  • Publication number: 20190336427
    Abstract: The present invention relates to a novel protein transduction domain (PTD), which is a peptide having an amino acid sequence represented by SEQ ID NO: 1, and a use thereof. When the peptide represented by SEQ ID NO: 1 of the present invention is used as a PTD, biological molecules (target materials) such as proteins, peptides, DNA and the like can be easily introduced into cells in a high yield.
    Type: Application
    Filed: October 26, 2017
    Publication date: November 7, 2019
    Applicant: BIOCELTRAN CO., LTD.
    Inventors: Sang Ho JANG, Gil Whoan LEE, Jung Soon HWANG, Jun Ho PARK, Ju Hee PARK
  • Patent number: 8609098
    Abstract: Disclosed are a composition for inhibiting hyperlipidemia and obesity through suppression of intestinal cholesterol absorption. An IgY-type antibody derived from yolk to NPC1L1 (Niemann-Pick C1-Like1), contained, as an active ingredient, in the composition of the present invention is linked to NPC1L1 (Niemann-Pick C1-Like1) that is a cholesterol transport protein in the intestines, thus interfering with binding between cholesterol and the transport protein to completely block absorption of cholesterol in the body and thereby prevent hyperlipidemia and obesity.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: December 17, 2013
    Assignees: Adbiotech Co., Ltd., Bioceltran Co., Ltd.
    Inventors: Sang Ho Jang, Soo Young Choi, Yeom Pyo Lee, Jae Jin An, Hong Gul Cheong, Hyuck Se Kwon, Jeong Keum Park, Doo Yeon Baek